P02-144 - Subjective Well-being Under Neuroleptics (SWN): a Predictor of Clinical and Psychosocial Outcome in Acute Patients. Preliminary Data

Abstract

Objectives: To evaluate the subjective well-being of a group of patients who were hospitalized at the Institute of Psychiatry (Novara), compared to the severity of illness. Methods: Patients are evaluated at admission and discharge through self-administration of the SWN (Subjective Well-being under Neuroleptics) scale, which contains five subscales (emotional regulation; self-control; mental functioning; social integration and physical functioning) assessing patients' psychophysical and emotional well-being, calculating a value for each subscale and a total score. The clinician fills in the CGI (Clinical Global Impression) for each patient, which provides a global judgement in three areas: severity of illness, global improvement and therapeutic effectiveness. Results: From June 2009, 51 patients were evaluated at admission and discharge: 26 diagnosed with psychosis and 25 diagnosed with personality disorders. Preliminary data suggest a meaningful improvement of the physical functioning in the psychotic group, a tendency to improvement of the social integration area in the personality disorders group. Among the psychotic group, the schizophrenic patients (n°=14) have shown an improvement in the self-control subscale. Conclusions: Literature suggests that a high SWN score is associated with a better compliance and an early improvement of subjective well-being is a major predictor of the chance of remission. This study will allow to compare the subjective well-being evaluated by SWN with the clinical judgment of the CGI and above all if this can represent a predictor index for the compliance and the chance of remission.

Reliability and Validity of Subjective Well-Being Under Neuroleptics Scale-Short Form-Turkish Version

“…It is because of this perspective that it is widely used in studies evaluating patients' quality of life, responses to antipsychotic treatment and drug side-effects (1,5,11,12). Some studies have reported that the score on the Subjective Well-Being Under Neuroleptics Scale is a good predictor of treatment response indicators, such as entering remission (9,13), drug compatibility (14), and quality of life (9,15). The original 38-item form of the scale was designed by Naber (1995) (10), who also developed a shortened, 20-item form (SWNS) (3).…”